HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HIF-2α expression is suppressed in SCLC cells, which survive in moderate and severe hypoxia when HIF-1α is repressed.

Abstract
Small cell lung carcinoma (SCLC) is extremely aggressive and frequently metastasizes widely in its early stage. Because tumor hypoxia is related to aggressive tumor behavior and the hypoxic adaptation of SCLC is poorly documented, we stained SCLC tumors arranged in a tissue microarray for hypoxia-inducible factor (HIF)-1α and HIF-2α proteins. We found an overall lack of HIF-2α protein expression, which was confirmed in large tumor sections. HIF-1α protein was strongly expressed in most tumors, frequently adjacent to necrotic regions. In concordance, cultured SCLC but not non-small cell lung carcinoma cells showed no or extremely low levels of HIF-2α mRNA and no HIF-2α protein at hypoxia. HIF-1α was stabilized after 4 hours at hypoxia, and its accumulation increased up to 96 hours. SCLC cells survived well and showed net proliferation and low cell death in modest (1% oxygen) and severe (0.1% oxygen) hypoxia. HIF-1α repression virtually did not influence cell death or viability despite reduced levels of hypoxia-inducible genes, such as BNIP3 and BNIP3L. At 1% oxygen no increased autophagy (LC3B-II activation) or NF-κB signaling were detected, whereas the unfolded protein response was activated at severe hypoxia. Our data indicate that HIFs are not exclusively required for SCLC cell survival at modest or severe hypoxia and that additional, yet uncharacterized, hypoxia-driven adaptation pathways may become activated.
AuthorsMatilda Munksgaard Persson, Martin E Johansson, Nastaran Monsef, Maria Planck, Siv Beckman, Michael J Seckl, Lars Rönnstrand, Sven Påhlman, Helen M Pettersson
JournalThe American journal of pathology (Am J Pathol) Vol. 180 Issue 2 Pg. 494-504 (Feb 2012) ISSN: 1525-2191 [Electronic] United States
PMID22115707 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Basic Helix-Loop-Helix Transcription Factors
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • NF-kappa B
  • RNA, Messenger
  • endothelial PAS domain-containing protein 1
Topics
  • Basic Helix-Loop-Helix Transcription Factors (deficiency, genetics)
  • Cell Hypoxia (genetics, physiology)
  • Cell Survival
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit (antagonists & inhibitors, genetics)
  • Lung Neoplasms (metabolism, physiopathology)
  • NF-kappa B (metabolism)
  • RNA, Messenger (metabolism)
  • Small Cell Lung Carcinoma (genetics, metabolism, physiopathology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: